Deliverables

  1. Home
  2. >
  3. Results
  4. >
  5. Deliverables

Work package 1: Programme management and coordination

  • Copy Link

Deliverable 1.5 Legal and Ethics Policy Paper, September 2018

Published: 24/09/2018
  • Copy Link

Deliverable 1.8 Establishment of Stakeholder Forum and Advisory Board

Published: 27/09/2017
  • Copy Link

Deliverable 1.2 Establishment of Governing Board, August 2019

Published: 01/03/2017, Updated: 13/08/2019
  • Copy Link

Grant agreement, November 2016

Published: 01/03/2017

Work package 2: Knowledge hub

  • Copy Link

Additional Deliverable 2.1 Training school: short review of the training methods and lessons learnt

Published: 23/03/2022
  • Copy Link

Deliverable 2.17 Second Report on the content and use of the online library

Published: 01/12/2021
  • Copy Link

Deliverable 2.13 2021 Strategy for the communication and dissemination of HBM4EU results

Published 14/04/2021
  • Copy Link

Deliverable 2.15 2021 Programme of training activities, materials and capacity building mechanisms

Published: 21/12/2020
  • Copy Link

Deliverable 2.14 Third review of training methods

Published: 26/11/2020
  • Copy Link

Deliverable 2.12 2020 Programme of training activities, materials and capacity building mechanisms

Published: 03/03/2020
  • Copy Link

Deliverable 2.10 2020 Strategy for the communication and dissemination of HBM4EU results

Published: 21/01/2020
  • Copy Link

Deliverable 2.11 2nd Review of Training Methods

Published: 21/01/2020
  • Copy Link

Deliverable 2.8 2019 Programme of training activities, materials and capacity building mechanisms

Published: 08/10/2019
  • Copy Link

Deliverable 2.9 Summary report on helpdesk activities

Published: 05/08/2019

Work package 4: Prioritisation and input to the annual work plan

  • Copy Link

Additional Deliverable 4.4 Report of the citizens’ focus groups

Published: 29/03/2022
  • Copy Link

Deliverable 4.8 Third list of HBM4EU priority substances

Published: 17/01/2022
  • Copy Link

Deliverable 4.10 2nd Report on stakeholder consultation and mapping of needs

Published: 19/08/2021
  • Copy Link

Additional Deliverable 4.2 Report of the citizens’ focus groups

Published: 19/02/2021
  • Copy Link

Deliverable 4.9 Scoping documents for 2021 for the first and second second round HBM4EU priority substances

Published: 11/12/2020
  • Copy Link

Additional Deliverable 4.3 Improvement of the strategy for the prioritisation of substances under HBM4EU

Published: 03/03/2020
  • Copy Link

Deliverable 4.7 Scoping documents for 2020 - 2nd set of priority substances - Update of policy questions and related HBM4EU activities

Published: 15/10/2019
  • Copy Link

Deliverable 4.6 Scoping documents for the second round priority substances

Published: 25/03/2019
  • Copy Link

Deliverable 4.5 Second list of HBM4EU priority substances and Chemical Substance Group Leaders for 2019-2021

Published: 03/09/2018
  • Copy Link

Deliverable Report 4.4 - First report on the stakeholder consultation and the mapping of needs

Published: 08/08/2018

Work package 5: Translation of results into policy

  • Copy Link

Deliverable 5.3 Scoping paper on the development of an indicator on chemical exposure in the European population

Published: 11/12/2017
  • Copy Link

Deliverable 5.2 1st substance-group specific derivation of EU-wide health-based guidance values

Update published: 22/06/2022
  • Copy Link

Additional Deliverable 5.1 A (phased) plan for action: how structured multi-actor dialogues on human biomonitoring results can facilitate targeted policy action (generic canvas for HBM4EU)

Published: 07/12/2017
  • Copy Link

Deliverable 5.1 Human biomonitoring in risk assessment: analysis of the current practice and 1st examples on the use of HBM in risk assessments of HBM4EU priority chemicals

Published: 16/11/2017
  • Copy Link

Deliverable 5.11 Human Biomonitoring in risk assessment: 4th set of examples on the use of HBM in risk assessments of HBM4EU priority chemicals (ANNEX)

Update published: 11/08/2022
  • Copy Link

Deliverable 5.11 Human Biomonitoring in risk assessment: 4th set of examples on the use of HBM in risk assessments of HBM4EU priority chemicals

Update published: 11/08/2022
  • Copy Link

Deliverable 5.12 4th substance specific derivation of HBM Guidance Values

Update published: 01/09/2022
  • Copy Link

Additional Deliverable 5.8 Indicators using HBM-GVs

Published: 22/06/2022
  • Copy Link

Additional Deliverable 5.7 Reporting for first and second set of substances (By CGLs)

Published: 22/06/2022
  • Copy Link

Additional Deliverable 5.6 Policy implications of the indicators

Published: 22/06/2022

Work package 6: Sustainability and capacity building

  • Copy Link

Additional Deliverable 6.5 NHCPs Final Report of Activities from Years 2017-2021

Published: 29/03/2022
  • Copy Link

Deliverable 6.6 HBM in Europe: legacy of HBM4EU and frameworks for medium- and long-term sustainability

Update published: 23/03/2022
  • Copy Link

Deliverable 6.4 Revised report on national needs, objectives of a long-term HBM4EU inventory of funding mechanisms and recommendations for a sustainable HBM initiative in Europe and its organisation

Published: 12/07/2021
  • Copy Link

Additional Deliverable 6.3 Legacy of HBM4EU for a new partnership

Published: 05/08/2020
  • Copy Link

Additional Deliverable 6.2 Results of the interaction and surveys with the Environment Protection Agency network and the National Reference Centre on Environment & Health

Published: 05/08/2020
  • Copy Link

Deliverable 6.5 Sustainability of HBM4EU in the future and related operational architecture concept: first report

Published: 13/08/2019
  • Copy Link

Deliverable 6.2 Revised set of key indicators

Published: 13/08/2019
  • Copy Link

Deliverable 6.3 Consultation on a sustainable HBM initiative in Europe

Published: 28/01/2019
  • Copy Link

Additional deliverable 6.1 Preliminary Report on different options for a sustainable EU HBM and feedback from different institutions

Published: 09/07/2019
  • Copy Link

Deliverable 6.1 First set of key indicators for HBM4EU, June 2017

Published: 26/06/2017

Work package 7: Survey design and fieldwork preparation

  • Copy Link

Deliverable 7.9 Overall report on WP7 documents for survey design, Study protocols, SOPs and Guidelines, and questionnaires

Published: 23/06/2021
  • Copy Link

Deliverable 7.8 Report on ongoing activities and existing data and data gaps

Published: 21/12/2020
  • Copy Link

Additional deliverable 7.1 Upgrade of the strategy for human sample exchange, including SOPs

Published: 06/09/2019
  • Copy Link

Deliverable 7.6 - 2nd prioritisation Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling

Published: 12/07/2021 (2nd update)
  • Copy Link

Deliverable 7.7 - 2nd set of materials for communication to participants, including informed consent

Published: 10/04/2019
  • Copy Link

Additional deliverable 7.2 Literature research and concept for a sample quality study on impact of thawing and freezing on integrity of human samples for selected 1st and 2nd priority substances

Published: 28/01/2019
  • Copy Link

Deliverable 7.5 Report on ongoing activities and existing data and data gaps for the 2nd prioritised substances

Published: 25/01/2019
  • Copy Link

Deliverable 7.4 1st material for communication to participants, including informed consent

Published: 17/07/2018
  • Copy Link

Deliverable 7.3 1st prioritisation Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling

Published: 12/07/2021 (update)
  • Copy Link

Deliverable 7.2 Strategy and SOPs for human sample exchange, including ethical demands

Published: 01/04/2020

Work package 8: Targeted field work surveys and alignment at EU level

  • Copy Link

Deliverable 8.12 Final report on HBM4EU Aligned Studies

Published: 22/06/2022
  • Copy Link

Deliverable 8.13 Final report on occupational studies

Published: 07/06/2022
  • Copy Link

Deliverable 8.11 Final report on targeted new fieldwork and results

Published: 07/06/2022
  • Copy Link

Deliverable 8.10 Final report on biobank activities completed

Published: 17/01/2022
  • Copy Link

Deliverable 8.9 Report on progress targeted occupational studies

Update published: 01/12/2021
  • Copy Link

Additional Deliverable 8.3 Implementation of effect biomarkers and implementation of 2nd set priority chemicals in the aligned studies

Published: 04/05/2021
  • Copy Link

Additional Deliverable 8.5 Summary Report of Task 8.2 Activities

Published: 26/11/2020
  • Copy Link

Deliverable 8.8 Progress report on strategies adopted to align HBM studies across Europe and preliminary results

Published: 29/05/2020
  • Copy Link

Additional Deliverable 8.4 Detailed research plan for the occupational diisocyanate and E-waste study

Published: 09/04/2020
  • Copy Link

Deliverable 8.6 Second report on biobank activities

Published: 23/01/2020

Work package 9: Laboratory analysis and quality assurance

  • Copy Link

Additional Deliverable 9.7 Partners performing chemical analyses of substances on the 2nd priority list in the aligned studies

Published: 04/04/2022
  • Copy Link

Additional Deliverable 9.9 Compilation of the analytical methods used by the HBM4EU laboratories for the substances on the 1st and 2nd prioritisation list

Published: 29/03/2022
  • Copy Link

Additional Deliverable 9.8 Concept for a stable and sustainable network of European analytical laboratories

Published: 23/03/2022
  • Copy Link

Deliverable 9.8 List of qualified laboratories: Scientific evaluation and the compilation of the lists of the laboratories that completed successfully the HBM4EU QA/QC programme for the substances included in the two prioritisation rounds

Published: 17/01/2022
  • Copy Link

Deliverable 9.9 Second report on analytical results and new methods developed

Published: 01/12/2021
  • Copy Link

Additional Deliverable 9.6 Partners performing chemical analyses of substances on the 1st priority list in the aligned studies

Published: 14/08/2020
  • Copy Link

Additional Deliverable 9.3 Report on activities in the analytical phase

Published: 27/12/2019
  • Copy Link

Deliverable 9.7 First report on analytical results and new methods development

Published: 08/10/2019
  • Copy Link

Deliverable 9.6 - Databases of candidate laboratories for the 2nd prioritisation round of substances

Published: 04/07/2019
  • Copy Link

Additional Deliverable 9.2 - Survey of tentative prices for biomarker analyses

Published: 12/04/2019

Work package 10: Data management and analysis

  • Copy Link

Deliverable 10.12 Update statistical analysis plan for the co-funded studies of WP8

Update published: 23/08/2022
  • Copy Link

Additional Deliverable 10.1 Final Data Management Plan (DMP)

Published: 16/06/2022
  • Copy Link

Deliverable 10.9 Third annual list of exposure distributions and/or European exposure values

Published: 14/02/2022
  • Copy Link

Deliverable 10.3 Report on user experiences in data exchange and data use in HBM4EU

Published: 07/02/2022
  • Copy Link

Deliverable 10.10 Statistical analysis plan for the co-funded studies of WP8

Published: 21/12/2020
  • Copy Link

Deliverable 10.7 Revised Data Management Plan (DMP)

Published: 11/12/2020
  • Copy Link

Deliverable 10.6 Second annual list of exposure distributions and/or European Reference Values

Published: 03/04/2020
  • Copy Link

Deliverable 10.5 Statistical Analysis Plan

Published: 01/03/2019
  • Copy Link

Deliverable 10.4 1st annual list of exposure distributions and/or European reference values

Published: 30/01/2019
  • Copy Link

Deliverable 10.2 Statistical Analysis Plan

Published: 03/01/2018

Work package 11: Linking HBM, health surveys and registers

  • Copy Link

Deliverable 11.5 Final evaluation report from the feasibility studies

Published: 01/12/2021
  • Copy Link

Deliverable 11.4 Second update on the report on opportunities and obstacles of combining HBM and health studies, availability of health studies and administrative registers and guidelines

Published: 18/10/2021
  • Copy Link

Additional Deliverable 11.3 Selection of feasibility studies for linking HBM and health studies, and linking to administrative data sources

Published: 10/01/2019
  • Copy Link

Deliverable 11.3 - Report on opportunities and obstacles of combining HBM and health studies, availability of health studies with biological samples, availability of administrative registers, and guidelines for combining HBM and health studies for the 2nd prioritisation round of substances

Published: 12/06/2019
  • Copy Link

Deliverable 11.2 - Report on workshop about opportunities and obstacles for linking HBM and health studies

Published: 15/02/2019
  • Copy Link

Deliverable 11.1 Report on opportunities and obstacles of combining HBM and health studies, availability of health studies with biological samples, availability of administrative registers, and guidelines for combining HBM and health studies

Published: 29/06/2018
  • Copy Link

Additional Deliverable 11.2 Criteria for feasibility studies

Published: 28/09/2017
  • Copy Link

Additional Deliverable 11.1 How can the results from BRIDGE Health be incorporated to the work of HBM4EU?

Published: 28/09/2017

Work package 12: From HBM to exposure

  • Copy Link

Additional Deliverable 12.13 Updates on the contribution to answering policy questions for the 1st and 2nd second set of priority substances

Published: 16/06/2022
  • Copy Link

Additional Deliverable 12.12 Completion of answers to selected policy questions for the 1st and 2nd second set of priority substances

Published: 16/06/2022
  • Copy Link

Deliverable 12.10 Report on risk characterisation ratios and evaluation of new regulatory thresholds for 2nd set of priority substances

Published: 07/0672022
  • Copy Link

Deliverable 12.8 Report on the results of exposure reconstruction algorithms on available HBM data in the EU for all priority compounds

Published: 04/04/2022
  • Copy Link

Deliverable 12.6 Integrated exposure modelling platform

Published: 04/04/2022
  • Copy Link

Deliverable 12.9 Report on estimation of relevant tissue and biological fluid doses of 2nd set of priority compounds in the EU population using refined PBTK modelling

Published: 29/03/2022
  • Copy Link

Deliverable 12.5: Risk characterisation of the 1st set of prioritised substances using external exposure estimated from HBM data: a methodological approach

  • Copy Link

Additional Deliverable 12.9 Report on biochemical/metabolic interactions among mixture components based on computational modelling

Published: 27/05/2021
  • Copy Link

Deliverable 12.7 Biological half-life and internal dosimetry of the 2nd set of priority compounds

Published: 29/10/2020
  • Copy Link

Additional Deliverable 12.10 Report on the parameterization of the 2nd set of priority compounds

Published: 29/05/2020

Work package 13: Establishing exposure health relationships

  • Copy Link

Deliverable 13.6 Final report on AOPs

Published: 22/06/2022
  • Copy Link

Deliverable 13.7 Final report on exposure-response associations based on pre-existing cohort data for the 1st and 2nd list of priority substances

Published: 07/06/2022
  • Copy Link

Additional Deliverable 13.8 Final report from IC2 projects on AOP networks

Published: 29/03/2022
  • Copy Link

Additional Deliverable 13.7 Draft guidance and recommendations for risk assessors and policymakers on the use of mechanistic toxicology data and AOPs

Published: 19/08/2021
  • Copy Link

Deliverable 13.4 Report on AOPs of priority substances

Published: 11/06/2020
  • Copy Link

Deliverable 13.5 Identified gaps for the establishment of AOPs and required studies

Published: 09/07/2019
  • Copy Link

Deliverable 13.3 - Inventory of available samples and data collected from existing cohorts and preliminary results on exposure- response associations for 1st list of priority substances

Published: 27/02/2019
  • Copy Link

Deliverable 13.2 Template for AOP update report for selected priority substances

Published: 29/06/2018
  • Copy Link

WP13&14-joint-activities-LEADERS-and-PARTNERS

The file contains tables with contacts to LEADERS (Table 1) who should coordinate discussions within chemical groups and OTHER PARTNERS (Table 2) who contributes with relevant chemical expertise. Published: 04/05/2018
  • Copy Link

Deliverable 13.1 Criteria for the selection of cohort studies, June 2017

Published: 20/07/2017

Work Package 14: Effect biomarkers

  • Copy Link

Deliverable 14.9 Report on the implementation of traditional and novel effect biomarkers for the 2nd set of prioritized substances

Published: 22/06/2022
  • Copy Link

Additional Deliverable 14.8 Development of an integrative framework that could synergise the toxicological and epidemiological knowledge for the implementation of effect biomarkers in a systematic way

Published: 16/06/2022
  • Copy Link

Additional Deliverable 14.7 Report of the 3rd Granada Workshop: State of development of WP14 interactions with other HBM4EU-WPs

Published: 16/06/2022
  • Copy Link

Deliverable 14.8 First report on the implementation of traditional and novel effect biomarkers for the 1st set of prioritised substances in the aligned studies

Published: 04/04/2022
  • Copy Link

Deliverable 14.7 Guidelines for the validation of biomarkers of effect: implementing quality assurance, trueness, precision, and accuracy as well as the availability of quality control measures by qualified laboratories

Published: 14/04/2021
  • Copy Link

Additional Deliverable 14.6 Report on the state of development of Task 14.3: Identification of needs for the implementation of both classical and new biomarkers of effect and decision criteria for their validation

Published: 26/11/2020
  • Copy Link

Deliverable 14.5 Selection criteria and inventory of effect biomarkers for the 2nd set of substances

Published: 12/03/2020
  • Copy Link

Additional Deliverable 14.5 Report on the 2nd Granada Workshop: Implementing Effect Biomarkers

Published: 10/07/2019
  • Copy Link

Additional Deliverable 14.3 - WP14 - WP13 Interaction: Delineation of AOPs for the selection of effect biomarkers in the HBM4EU aligned studies Bisphenol A as a case-study

Published: 10/04/2019
  • Copy Link

Deliverable 14.3 Report on available biomarkers of effect of utility in human epidemiological studies for the 1st set of prioritised substances

Published: 30/01/2019

Work package 15: Mixtures, HBM and human health risks

  • Copy Link

Deliverable 15.7 Report on re-analysis of existing HBM data for priority substances to identify mixtures

Published: 22/06/2022
  • Copy Link

Deliverable 15.6 Results of the joint survey on HBM mixtures

Published: 22/06/2022
  • Copy Link

Deliverable 15.8 Lessons-learnt from HBM4EU WP15 on mixtures: intermediate recommendations

Published: 05/04/2022
  • Copy Link

Deliverable 15.5 Case study reports on mixture health effects

Published: 12/07/2021
  • Copy Link

Deliverable 15.4 Report on approaches to identify mixture health effects

Published: 03/03/2020
  • Copy Link

Deliverable 15.1 Information needs from policy makers translated in terms of functionality of HBM mixture information

Published: 23/01/2020
  • Copy Link

Additional Deliverable 15.7 Joint survey of pesticides: details of approach and contributions

Published: 22/10/2019
  • Copy Link

Additional Deliverable 15.1 Plan for development of case studies

Published: 21/03/2019
  • Copy Link

Deliverable 15.3 Report real-life exposure profiles from re-analysis of existing HBM mixture data

Published: 28/01/2019
  • Copy Link

Additional Deliverable 15.3 HBM mixture database description and proposal statistical analysis plan

Published: 03/01/2018

Work package 16: Emerging chemicals

  • Copy Link

Deliverable 16.3 Report on generated HBM data and global framework for emerging chemicals

Published: 29/04/2022
  • Copy Link

Additional Deliverable 16.6 Last updated version of the elaborated inventory of already identified chemicals of emerging concern coupled to the developed MS reference library for annotation, capable to be released as a public and sustainable resource

Published: 29/03/2022
  • Copy Link

Deliverable 16.4 Emerging exposure markers database - Reference Mass Spectral Libraries for Suspect Screening of Chemicals of Emerging Concern

Published: 17/06/2021
  • Copy Link

Additional Deliverable 16.5 Updated prioritised list of known emerging chemicals. Updated list of known chemicals (parent compounds or metabolites) to be considered as exposure markers of emerging concern

Published: 07/10/2019
  • Copy Link

Additional Deliverable 16.2 - Emerging chemicals framework

Published: 15/02/2019
  • Copy Link

Deliverable 16.2 Workflow for screening emerging chemicals

Published: 28/01/2019
  • Copy Link

Additional Deliverable 16.4 Emerging Substances

Published: 21/12/2018
  • Copy Link

Additional Deliverable 16.3 Direct effect based approaches applied to the screening of emerging substances

Published: 03/01/2018
  • Copy Link

Additional Deliverable 16.1 Screening methods inventory

Published: 03/01/2018
  • Copy Link

Deliverable 16.1 Prioritised list of known emerging chemicals

Published: 03/01/2018